MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517048073 A) filed by Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, Germany, on May 19, for 'novel substituted pyrazine-carboxamide derivatives.'
Inventor(s) include Pfau, Roland; Dahmann, Georg.; Du Hoffmann, Johann Faustus; Giovannini, Riccardo; Gerlach, Kai; Hohn, Christoph; Just, Stefan; Lehmann, Thorsten; Pekcec, Anton; Peters, Stefan; Schlichtiger, Julia; Sommer, Heiko; Specker, Christian; and Wiedenmayer, Dieter.
The application for the patent was published on June 6, under issue no. 23/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to compounds of formula I, a process for their manufacture, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of conditions having an association with the function of metabotropic glutamate receptor subtype 4 (mGluR4). A, R1, R2, R3, R4, R5 and R6 have meanings given in the description."
The patent application was internationally filed on Oct. 27, 2023, under International application No.PCT/EP2023/080028.
Disclaimer: Curated by HT Syndication.
